Safety and efficacy of aspirin for primary prevention of cancer: a meta-analysis of randomized controlled trials
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Link
http://link.springer.com/content/pdf/10.1007/s00432-019-02932-0.pdf
Reference27 articles.
1. Belch J, MacCuish A, Campbell I et al (2008) The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease. BMJ 337:a1840
2. Brighton TA, Eikelboom JW, Mann K et al (2012) Low-dose aspirin for preventing recurrent venous thromboembolism. N Engl J Med 367:1979–1987
3. Chubak J, Whitlock EP, Williams SB, Kamineni A, Burda BU, Buistand DS, Anderson ML (2016) Annals of internal medicine aspirin for the prevention of cancer incidence and mortality : systematic evidence reviews for the U.S. Preventive Services. Ann Int Med 164(12):814–825
4. Collaborative Group of the Primary Prevention Project (2001) Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Lancet 357:89–95
5. Cook NR, Lee IM, Zhang SM et al (2013) Alternate-day, low-dose aspirin and cancer risk: long-term observational follow-up of a randomized trial. Ann Intern Med 159:77–85
Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Exploring the health benefits of Ganoderma : bioactive compounds and mechanisms of action; immunomodulatory, and anti-tumour activities;New Zealand Journal of Botany;2024-07-22
2. Aspirin vs Placebo as Adjuvant Therapy for Breast Cancer;JAMA;2024-05-28
3. Prophylactic aspirin intake and breast cancer risk; A systematic review and meta-analysis of observational cohort studies;European Journal of Surgical Oncology;2023-10
4. Health Crisis and Cancer Prevention: Friend or Foe;Handbook of Cancer and Immunology;2023
5. Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer;JAMA;2022-04-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3